Here are relevant reports on : clinical-mass-spectrometry-market
-
U.S. Wealth Management Industry – Special Focus on Mass Affluent Segment
The recent economic crisis significantly decreased client trust in wealth management firms, resulting in a shift toward personalized services and safer products such as fixed income securities. However, the mass affluent offer the wealth management industry high growth opportunities. In the U.S., this segment has around 33 million individuals, representing around 43% of the country’s investable assets. However, only 18% of the mass affluent are estimated to have availed financial planning services.
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
World Healthcare IT (Provider and Payor) Market - Clinical (EMR, PACS, RIS, CPOE, LIS) & Non-Clinical (RCM, Billing, Claims) Information systems Trends, opportunities & Forecast till 2015
The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015. Need to cut healthcare costs, enhance clinical/administrative workflow of hospitals, and huge demand for faster, error-free, efficient healthcare delivery, is fueling the healthcare provider IT market worldwide. Furthermore, the initiatives taken by the government for adoption of healthcare IT systems globally are also a significant driving force. Some of the major initiatives expected to hugely impact the market are the U.S Healthcare reforms and ARRA incentives.
- Published: August 2011
- Price: $ 4950
- TOC Available:
-
Predictive Clinical Biomarkers Market by Product & Service (Consumable, Software), Technology (NGS, PCR), Disease (Cancer, Infectious), Application (Clinical Diagnostics)-Forecast to 2030
The predictive clinical biomarkers market, valued at US$7.84 billion in 2024, stood at US$8.49 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$14.69 billion by the end of the period. he market for predictive clinical biomarkers is growing rapidly as the healthcare industry shifts toward personalized and predictive medicine.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031
The Europe companion animal diagnostics market, valued at USD0.43 billion in 2025, stood at USD0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of USD0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare IT Market by Solution [Clinical (EHR, PACs & VNA, Telehealth, CDSS, Medical Image), Nonclinical (Clinical Analytics, RCM, Interoperability), Service (Claim, Billing)], End User [Hospital, ASC, Pharmacy, Payer]-Forecast to 2030
The Asia Pacific Healthcare IT market, valued at USD 68.96 billion in 2024, stood at USD 80.69 billion in 2025 and is projected to advance at a resilient CAGR of 17.6% from 2025 to 2030, culminating in a forecasted valuation of USD 181.30 billion by the end of the period. The Asia Pacific healthcare IT market is growing steadily, driven by increasing healthcare digitalization, rising patient volumes, government initiatives to adopt health IT, and expanding use of cloud, AI, and analytics in the region.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Environmental Mass Spectrometry Market by Component (Detector, Mass analyzer, Vacuum System), Product (Triple Quad, Q-ToF, FTMS, Quad, ToF), Application (PM, VoC, PFAS, pesticide, wastewater), Installed Base & Replacement Rate - Global Forecasts to 2031
The environmental mass spectrometry market, valued at US$0.86 billion in 2024, stood at US$0.93 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2031, culminating in a forecasted valuation of US$1.47 billion by the end of the period. The key driving factors include rising regulatory pressure for ultra-low detection limits in water and air monitoring, increasing demand for real-time and predictive environmental analysis of VOCs and industrial pollutants, and the growing integration of artificial intelligence and machine learning with mass spectrometry for advanced environmental data interpretation.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Mass Spectrometry Market by Component (Detector, Mass Analyzer, Ion Source, Vacuum System), Product (Triple Quad, Q-ToF, FTMS, Quad, ToF), Application (Omics, Environment, Pharma, Biopharma), Installed Base & Replacement Rate - Forecast to 2031
The Europe mass spectrometry market, valued at USD 1.69 billion in 2024, stood at USD 1.83 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2031, culminating in a forecasted valuation of USD 2.83 billion by the end of the period. The Europe mass spectrometry market is growing due to its expanding use across diverse applications, including proteomics, metabolomics, lipidomics, pharmacokinetics, environmental analysis, forensic toxicology, food safety, and single-cell analysis.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
